Futures are pointing to a lower Wall Street open, with China ramping up its rhetoric in the ongoing trade dispute with the U.S.Morning Briefread more
A Ministry of Commerce spokesperson did not mention any U.S. actions specifically, but it's been a tense couple of weeks for the trade negotiations.World Politicsread more
U.S. stock index futures were sharply lower Thursday as U.S.-China trade worries persisted with more companies suspending business with Chinese telecom giant Huawei.US Marketsread more
British Prime Minister Theresa May could announce her resignation in the next few days, according to U.K. media reports, as she faces increasing pressure from members of her...Europe Politicsread more
A federal judge in New York City on Wednesday said Deutsche Bank and Capital One can turn over financial documents related to President Donald Trump and his businesses in...Politicsread more
With Tesla shares skidding, two experts weigh in on what could be next for the automaker and its volatile stock.Trading Nationread more
Strategist Robert Buckland says global stocks have gained 7% on an annualized rate since 2010, which how much dividends have gone up in that time.Marketsread more
Analysts at Barclays "can't believe it's not meat," projecting huge growth for the nascent alternative food industry over 10 years.Investingread more
Chinese government-aligned experts are stressing that the U.S. will need to negotiate a trade agreement with Asia's largest economy.China Economyread more
Under-the-radar hedge-fund managers beating the market are betting on big comeback stories General Electric and PG&E, as well as Biogen.Marketsread more
Deere & Co.: "I think John Deere is such a buy. When you talk about trade and Europeans, they should let more Deere stuff in. I think Deere is terrific. And the Europeans better start playing ball with us, that's what I have to say."
TherapeuticsMD Inc: "It's done nothing … It ain't workin', it ain't workin'. I'm gonna have to say don't buy. I just have to put it like that."
Box Inc.: "I like that upgrade. I wanted to call [CEO] Aaron [Levie]. Aaron, I believe that was a good upgrade. I agree with it. I still think the company should be acquired, but Aaron's too young to want to sell."
Cummins Inc.: "It's regarded as a China play. Is that right that its regarded as a china play? Well, it's got a lot of business in China, but it really is. There was an upgrade and a downgrade today. I read through it. I actually thought the quarter was fine. It's got a 3 percent yield. I'm not worried ... I think that when you buy that stock with a 3 percent yield and you buy it a little bit lower after, you're going to do well. But don't look at it tomorrow or the next day, because it wont do well until we get a china deal. Even though it should be doing well."
Verizon Communications Inc.: "Clean. Good. Solid. Good yield. Verizon, terrific stock."
Morgan Stanley: "I want you to buy it. [CEO] James Gorman had one of the best quarters that everybody hated. That's true. It was not a miss, it was not clean, it was not perfect. And that's where the opportunity comes. I say Morgan Stanley is great, I say Oregon is great and I like Dutch Brothers coffee when I'm out there."
Canopy Growth Corp.: "I feel this last move from $45 to $50 needs time to digest. I'm walking away from now. If it goes to $60, it's going to do without me. I don't mind. I've been behind it a long time and I don't want tog get anybody hurt."
Principal Financial Group Inc.: "Four-and-a-half percent yield. Eight times earnings. I mean give me a break. You're going to be fine with Principal. I know people don't like the yield curve, that's what they get hurt by. I think it's a fine steady as she goes company and all of us who remember in 2007 and 9 and tried to write it off were wrong."
Johnson & Johnson: "[CEO] Alex Gorsky is doing a terrific job and I think that—look, my heart goes out to anybody that has ovarian cancer—but my take is that they did not cause these problems. And that you should buy it."
Disclosure: Cramer's charitable trust owns shares of Johnson & Johnson.